enVVeno Medical Corporation (NASDAQ:NVNO – Get Free Report)’s share price dropped 4.1% during trading on Wednesday . The stock traded as low as $5.10 and last traded at $5.10. Approximately 70,698 shares changed hands during trading, a decline of 22% from the average daily volume of 90,648 shares. The stock had previously closed at $5.32.
enVVeno Medical Stock Performance
The stock has a fifty day simple moving average of $5.42 and a two-hundred day simple moving average of $5.27. The stock has a market cap of $67.98 million, a PE ratio of -3.07 and a beta of 1.22.
enVVeno Medical (NASDAQ:NVNO – Get Free Report) last announced its earnings results on Wednesday, July 31st. The company reported ($0.31) earnings per share for the quarter. On average, equities analysts predict that enVVeno Medical Corporation will post -1.3 EPS for the current fiscal year.
Institutional Inflows and Outflows
enVVeno Medical Company Profile
enVVeno Medical Corporation (Nasdaq: NVNO) is an medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. The company’s lead product, the VenoValve®️, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).
Featured Stories
- Five stocks we like better than enVVeno Medical
- P/E Ratio Calculation: How to Assess Stocks
- How Much Can You Make in Stocks in One Month?
- What is the S&P 500 and How It is Distinct from Other Indexes
- This Is the Top Large-Cap Stock Insiders Are Buying
- Investing In Preferred Stock vs. Common Stock
- Capitalize on Micron’s 24% Drop—Wall Street Eyes Major Upside
Receive News & Ratings for enVVeno Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for enVVeno Medical and related companies with MarketBeat.com's FREE daily email newsletter.